Yarbrough Capital, LLC Neogenomics Inc Transaction History
Yarbrough Capital, LLC
- $2.58 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$194 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$140 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$64.2 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$60.7 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$60.6 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.24B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...